Vinay Badhwar, MD; Sreekanth Vemulapalli, MD; Michael A. Mack, MD; et al.
free access
JAMA Cardiol. 2020;5(10):1092-1101. doi:10.1001/jamacardio.2020.2221
This cross-sectional study assesses national 30-day and 1-year outcomes of mitral valve surgery and defines the hospital- and surgeon-level volume-outcome associations for mitral valve repair or replacement in patients with primary mitral regurgitation.
Brigitta Gahl, PhD; Mevlüt Çelik, MD; Stuart J. Head, MD, PhD; et al.
free access
JAMA Cardiol. 2020;5(10):1102-1112. doi:10.1001/jamacardio.2020.2497
This systematic review and meta-analysis examines the natural history of asymptomatic aortic stenosis and the association of early intervention with survival.
Jared M. O’Leary, MD; Marie-Annick Clavel, DVM, PhD; Shmuel Chen, MD, PhD; et al.
free access
JAMA Cardiol. 2020;5(10):1113-1123. doi:10.1001/jamacardio.2020.2614
This cohort study evaluates the associations of elevated B-type natriuretic peptide levels after transcatheter aortic valve replacement (TAVR) and change in B-type natriuretic peptide levels between follow-up time points with risk of subsequent clinical outcomes.
-
Editor's Note
Natriuretic Peptide Levels After Transcatheter Aortic Valve Replacement
Robert O. Bonow, MD, MS; Patrick T. O’Gara, MD
JAMA Cardiol
Maciej Banach, MD, PhD; P. Barton Duell, MD; Antonio M. Gotto Jr, MD, DPhil; et al.
open access
JAMA Cardiol. 2020;5(10):1124-1135. doi:10.1001/jamacardio.2020.2314
This pooled analysis of data from 4 completed phase 3 randomized clinical trials assesses the efficacy and safety associated with administration of bempedoic acid vs placebo among patients with hypercholesterolemia and atherosclerotic cardiovascular disease with or without heterozygous familial hypercholesterolemia who were receiving statins and among patients with hypercholesterolemia and statin intolerance.
Rishi Puri, MBBS, PhD; Steven E. Nissen, MD; Benoit J. Arsenault, PhD; et al.
free access
JAMA Cardiol. 2020;5(10):1136-1143. doi:10.1001/jamacardio.2020.2413
This secondary analysis of the randomized clinical ACCELERATE trial examines whether lipoprotein(a)-associated cardiovascular risk is modulated by systemic inflammation in optimally treated patients at high risk for cardiovascular disease.
Venkatesh L. Murthy, MD, PhD; Bing Yu, PhD; Wenshuang Wang, PhD; et al.
free access
JAMA Cardiol. 2020;5(10):1144-1153. doi:10.1001/jamacardio.2020.2686
This cohort study defines a molecular basis for cardiometabolic stress and assesses its associations with cardiovascular prognosis.
Pamela H. Lai, MD, PhD, MSc; Elizabeth A. Lancet, DrPH, MPH; Michael D. Weiden, MS, MD; et al.
open access
JAMA Cardiol. 2020;5(10):1154-1163. doi:10.1001/jamacardio.2020.2488
This cross-sectional study describes the characteristics associated with outpatient cardiac arrests and death during the coronavirus disease 2019 pandemic in New York City.
-
Editor's Note
Heroism in the Face of the COVID-19 Pandemic
Ajay J. Kirtane, MD, SM; Roxana Mehran, MD; Ann Marie Navar, MD, PhD; Robert O. Bonow, MD, MS
JAMA Cardiol